We are pleased to see that the Pradaxa litigation is moving forward. Our firm continues to receive frequent inquiries from Pradaxa patients who suffered life-threatening bleeding, allegedly due to their use of this medication.
New York, New York (PRWEB) November 28, 2012
Pradaxa lawsuits continue to move forward in the multidistrict litigation established in U.S. District Court, Southern District of Illinois, Bernstein Liebhard LLP reports. In a Case Management Order issued on November 19, 2012, U.S. District Judge David Herndon detailed a production schedule that set forth deadlines for Boehringer Ingelheim Pharmaceuticals, Inc. to produce evidence in the litigation.* According to court records, 138 Pradaxa bleeding lawsuits are currently pending in the Southern District of Illinois. (In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation – MDL No. 2385)
“We are pleased to see that the Pradaxa litigation is moving forward. Our firm continues to receive frequent inquiries from Pradaxa patients who suffered life-threatening bleeding, allegedly due to their use of this medication,” says Bernstein Liebhard LLP, a national law firm representing clients who have been injured by dangerous drugs and defective medical devices. The firm is currently offering free and confidential lawsuit evaluations to individuals who suffered serious Pradaxa side effects.
Pradaxa was approved in October 2010 to prevent strokes in people with a heart-rhythm disorder known as atrial fibrillation. According to a recent report from The New York Times, Pradaxa has garnered more than $1 billion in sales during its two years on the market. However, in that short time period, the drug has been linked to more than 500 cases of fatal bleeding in the U.S.**
Pradaxa was supposed to be an improvement over warfarin, a blood thinner which has been on the market for decades. While both medications can cause serious internal bleeding, warfarin hemorrhaging can be stopped via the administration of vitamin k. However, there is no readily available antidote for Pradaxa bleeding. While dialysis can be used to remove Pradaxa from the blood stream, a study published in May in the journal, Neurology, found this treatment is risky and may not be administered quickly enough to stop Pradaxa bleeding.***
Victims of serious Pradaxa bleeding may be eligible to collect compensation for their medical bills, lost wages, pain and suffering and more. To learn more about filing a Pradaxa lawsuit, please visit our website http://www.consumerinjurylawyers.com/, or call 1-877-779-1414 to speak with one of our Pradaxa lawyers today.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP